GALAXYSURF Q4 FY25 Concall Summary & Key Takeaways (GALAXYSURF)

GALAXYSURF Q4 FY25 (Mar-2025 Qtr) Earnings call highlights: Key takeaways, performance, financial metrics, outlook and guidance, concerns and management tone.

Galaxy Surfactants Ltd (GALAXYSURF) Q4FY25 Concall Summary - Mar-2025 Qtr

Performance Overview

  • Galaxy Surfactants reported a consolidated EBITDA of INR135 crores in Q4 FY25, a 23% sequential growth over Q3.
  • EBITDA per metric ton saw a significant improvement, increasing by 24% QoQ and 5% YoY to INR21,715.
  • Rest of the World segment registered double-digit growth in both Q4 and full FY25, driven by expansion in Europe, APAC, North America, and Latin America.
  • India and AMET regions experienced flat performance in both Q4 and full FY25 due to slow recovery in demand and supply chain disruptions.
  • Galguard Prebiotive, a new product innovation, received the Best Ingredient Silver Award at in-cosmetics global exhibition in Amsterdam.

Financial Metrics

Log in to Stocksigma to read the Financial Metrics section of this summary.

Operating Performance / Business Segments

Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.

Key Discussions & Insights

Log in to Stocksigma to read the Key Discussions & Insights section of this summary.

Outlook and Guidance

Log in to Stocksigma to read the Outlook and Guidance section of this summary.

Challenges / Concerns

Log in to Stocksigma to read the Challenges / Concerns section of this summary.

Industry / Competitive Landscape

Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.

Overall Summary

Log in to Stocksigma to read the Overall Summary section of this summary.